MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$91.83
-6.99 (-7.07%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+24.21%
YTD
+17.63%
Open$98.76
Previous Close$98.82
Day High$98.76
Day Low$91.73
52W High$130.00
52W Low$63.23
Volume—
Avg Volume635.8K
Market Cap6.42B
P/E Ratio—
EPS$-14.55
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$87.61
Above
SMA 200
$68.12
Above
RSI (14)
56.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-27.3% upside
Current
$91.83
$91.83
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 725.66M | 383.68M | 354.29M |
| Net Income | -32,519,720 | -15,474,936 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 2.93M | 1.47M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |